Literature DB >> 31131238

Retinal nerve fiber layer changes based on historic CD4 nadir among HIV positive patients undergoing glaucoma evaluation.

Sarah H Van Tassel1, Paul Petrakos1, Elizabeth Marlow1, Elizabeth Mauer2, Harjot K Singh3, Anna M Demetriades1.   

Abstract

AIM: To determine relationships between retinal nerve fiber layer (RNFL) thickness and nadir CD4 cell count in human immunodeficiency virus (HIV) positive patients evaluated for glaucoma suspicion.
METHODS: Data were reviewed for 329 HIV positive patients evaluated for glaucoma suspicion. High-definition optical coherence tomography (OCT) RNFL measurements were obtained at least 6mo apart. Analyses were performed to identify relationships between nadir CD4 count and RNFL thickness.
RESULTS: Totally 110 eyes of 55 patients met inclusion criteria, of which 46 eyes were from subjects with nadir CD4<200 cells/mm3 and 64 had nadir CD4≥200 cells/mm3. Patients with nadir CD4<200 cells/mm3 had significantly thicker superior (119.7±18.6 µm) and temporal (63.8±11.7 µm) quadrants at time of initial OCT compared to the superior (112.8±16.8 µm, P=0.048) and temporal (57.1±11.9 µm, P=0.004) quadrants of patients with higher nadir CD4. This trend toward thicker RNFL among subjects with lower nadir CD4 cell counts persisted at the time of follow up OCT where participants with nadir CD4<200 cells/mm3 showed average RNFL thickness in the superior and temporal quadrants of 117.9±18.3 µm and 63.8±12.8 µm, respectively, compared to a superior thickness of 110.5±16.9 µm (P=0.034) and temporal thickness of 57.3±11.6 µm (P=0.007) among those with higher nadir CD4.
CONCLUSION: Patients with lower nadir CD4 cell counts have thicker RNFL in the superior and temporal quadrants compared to those with higher nadir CD4 counts. RNFL thickness in HIV positive patients may be affected by historic HIV disease control and should be considered when evaluating HIV positive patients for glaucoma.

Entities:  

Keywords:  glaucoma; glaucoma suspect; human immunodeficiency virus; retinal nerve fiber layer

Year:  2019        PMID: 31131238      PMCID: PMC6520263          DOI: 10.18240/ijo.2019.05.14

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  26 in total

1.  Pattern of early visual field loss in HIV-infected patients.

Authors:  P A Sample; D J Plummer; A J Mueller; K I Matsubara; A Sadun; I Grant; W R Freeman
Journal:  Arch Ophthalmol       Date:  1999-06

2.  AIDS and ophthalmology, 2008.

Authors:  Douglas A Jabs
Journal:  Arch Ophthalmol       Date:  2008-08

3.  Contrast sensitivity and color vision in HIV-infected individuals without infectious retinopathy.

Authors:  Kayur H Shah; Gary N Holland; Fei Yu; Mark Van Natta; Steven Nusinowitz
Journal:  Am J Ophthalmol       Date:  2006-08       Impact factor: 5.258

4.  Retinal nerve fiber layer evaluation in human immunodeficiency virus-positive patients.

Authors:  D J Plummer; D U Bartsch; S P Azen; S Max; A A Sadun; W R Freeman
Journal:  Am J Ophthalmol       Date:  2001-02       Impact factor: 5.258

5.  Objective analysis of retinal damage in HIV-positive patients in the HAART era using OCT.

Authors:  Igor Kozak; Dirk-Uwe Bartsch; Lingyun Cheng; Brian R Kosobucki; William R Freeman
Journal:  Am J Ophthalmol       Date:  2005-02       Impact factor: 5.258

6.  Objective analysis of retinal function in HIV-positive children without retinitis using optical coherence tomography.

Authors:  Marilita M Moschos; Glykeria Mostrou; Eleni Psimenidou; Vasiliki Spoulou; Maria Theodoridou
Journal:  Ocul Immunol Inflamm       Date:  2007 Jul-Aug       Impact factor: 3.070

7.  The study to understand the natural history of HIV and AIDS in the era of effective therapy (SUN Study).

Authors:  Claudia Vellozzi; John T Brooks; Timothy J Bush; Lois J Conley; Keith Henry; Charles C J Carpenter; E Turner Overton; John Hammer; Kathy Wood; Scott D Holmberg
Journal:  Am J Epidemiol       Date:  2008-12-13       Impact factor: 4.897

8.  Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.

Authors:  Matthias Egger; Margaret May; Geneviève Chêne; Andrew N Phillips; Bruno Ledergerber; François Dabis; Dominique Costagliola; Antonella D'Arminio Monforte; Frank de Wolf; Peter Reiss; Jens D Lundgren; Amy C Justice; Schlomo Staszewski; Catherine Leport; Robert S Hogg; Caroline A Sabin; M John Gill; Bernd Salzberger; Jonathan A C Sterne
Journal:  Lancet       Date:  2002-07-13       Impact factor: 79.321

9.  Vision function in HIV-infected individuals without retinitis: report of the Studies of Ocular Complications of AIDS Research Group.

Authors:  William R Freeman; Mark L Van Natta; Douglas Jabs; Pamela A Sample; Alfredo A Sadun; Jennifer Thorne; Kayur H Shah; Gary N Holland
Journal:  Am J Ophthalmol       Date:  2008-01-11       Impact factor: 5.258

10.  Scanning laser polarimetry demonstration of retinal nerve fiber layer damage in human immunodeficiency virus-positive patients without infectious retinitis.

Authors:  Igor Kozak; Dirk-Uwe G Bartsch; Lingyun Cheng; Allen McCutchan; Robert N Weinreb; William R Freeman
Journal:  Retina       Date:  2007 Nov-Dec       Impact factor: 4.256

View more
  2 in total

1.  The Prevalence of Autoimmune Diseases in Patients with Primary Open-Angle Glaucoma Undergoing Ophthalmic Surgeries.

Authors:  Maltish M Lorenzo; Julia Devlin; Chhavi Saini; Kin-Sang Cho; Eleftherios I Paschalis; Dong Feng Chen; Rafaella Nascimento E Silva; Sherleen H Chen; Milica A Margeta; Courtney Ondeck; David Solá-Del Valle; James Chodosh; Joseph B Ciolino; Roberto Pineda; Louis R Pasquale; Lucy Q Shen
Journal:  Ophthalmol Glaucoma       Date:  2021-08-18

2.  Macular Changes Observed on Optical Coherence Tomography Angiography in Patients Infected With Human Immunodeficiency Virus Without Infectious Retinopathy.

Authors:  Kui-Fang Du; Xiao-Jie Huang; Chao Chen; Wen-Jun Kong; Lian-Yong Xie; Hong-Wei Dong; Wen-Bin Wei
Journal:  Front Med (Lausanne)       Date:  2022-04-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.